» Articles » PMID: 27206851

Microglia Activation and Polarization After Intracerebral Hemorrhage in Mice: the Role of Protease-Activated Receptor-1

Overview
Publisher Springer
Date 2016 May 22
PMID 27206851
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Polarized microglia play a dual (beneficial/detrimental) role in neurological diseases. However, the status and the factors that modulate microglia polarization in intracerebral hemorrhage (ICH) remain unclear. In the present study, we investigated the role of protease-activated receptor-1 (PAR-1, a thrombin receptor) in ICH-induced microglia polarization in mice. Male wild-type (WT) and PAR-1 knockout (PAR-1 KO) mice received an infusion of 30-μL autologous blood or saline into the right basal ganglia. Mice were euthanized at different time points and the brains were used for Western blotting and immunohistochemistry. Some mice had magnetic resonance imaging. We found that ICH induced microglia activation and polarization. M1 phenotypic markers were markedly increased and reached a peak as early as 4 h, remained high at 3 days and decreased 7 days after ICH. M2 phenotypic markers were upregulated later than M1 markers reaching a peak at day 1 and declining by day 7 after ICH. PAR-1 was upregulated after ICH and expressed in the neurons and microglia. ICH induced less brain swelling and neuronal death in PAR-1 KO mice, and this was associated with less M1 polarization and reduced proinflammatory cytokine levels in the brain. In conclusion, these results suggest that polarized microglia occur dynamically after ICH and that PAR-1 plays a role in the microglia activation and polarization.

Citing Articles

Microglial Mechanisms and Therapeutic Potential in Brain Injury Post-Intracerebral Hemorrhage.

Gong Y, Li H, Cui H, Gong Y J Inflamm Res. 2025; 18:2955-2973.

PMID: 40026311 PMC: 11872102. DOI: 10.2147/JIR.S498809.


Microglia-derived ADAM9 promote GHRH neurons pyroptosis by Mad2L2-JNK-caspase-1 pathway in subarachnoid hemorrhage.

Mao J, Bao Y, Liu F, Ye Q, Peng J, Nie J J Neuroinflammation. 2024; 21(1):302.

PMID: 39563331 PMC: 11575213. DOI: 10.1186/s12974-024-03299-x.


Revolutionising Neurological Therapeutics: Investigating Drug Repurposing Strategies.

Attri M, Raghav A, Sinha J CNS Neurol Disord Drug Targets. 2024; 24(2):115-131.

PMID: 39323347 DOI: 10.2174/0118715273329531240911075309.


Systemic immune-inflammation index and serum glucose-potassium ratio predict poor prognosis in patients with spontaneous cerebral hemorrhage: An observational study.

Liu Y, Qiu T, Fu Z, Wang K, Zheng H, Li M Medicine (Baltimore). 2024; 103(29):e39041.

PMID: 39029027 PMC: 11398737. DOI: 10.1097/MD.0000000000039041.


Silencing CXCL16 alleviate neuroinflammation and M1 microglial polarization in mouse brain hemorrhage model and BV2 cell model through PI3K/AKT pathway.

Dingyi L, Libin H, Jifeng P, Ding Z, Yulong L, Zhangyi W Exp Brain Res. 2024; 242(8):1917-1932.

PMID: 38896294 DOI: 10.1007/s00221-024-06875-y.


References
1.
Xue M, Hollenberg M, Demchuk A, Yong V . Relative importance of proteinase-activated receptor-1 versus matrix metalloproteinases in intracerebral hemorrhage-mediated neurotoxicity in mice. Stroke. 2009; 40(6):2199-204. DOI: 10.1161/STROKEAHA.108.540393. View

2.
Zhou Y, Wang Y, Wang J, Stetler R, Yang Q . Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol. 2013; 115:25-44. DOI: 10.1016/j.pneurobio.2013.11.003. View

3.
McLaughlin J, Patterson M, Malik A . Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci U S A. 2007; 104(13):5662-7. PMC: 1838494. DOI: 10.1073/pnas.0700763104. View

4.
Xi G, Keep R, Hua Y, Xiang J, Hoff J . Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke. 1999; 30(6):1247-55. DOI: 10.1161/01.str.30.6.1247. View

5.
Martinez F, Helming L, Gordon S . Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2008; 27:451-83. DOI: 10.1146/annurev.immunol.021908.132532. View